Ross Toohey
Managing Director
Ross Toohey is a seasoned entrepreneur, business advisor, and M&A strategist with a distinguished career in strategic growth, mergers and acquisitions (M&A), marketing, and business development. He has over two decades of experience driving enterprise value across healthcare, pharma/biotech, marketing, and business transformation. With a career spanning founder-led startups to billion-dollar enterprises, he brings strategic clarity and operational precision to help businesses scale profitably and achieve Extraordinary Exits™.
Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America’s largest independent firms as well as received the “Healthcare Agency of the Year” award for three consecutive years. Ross also spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.
In 2019, Ross led the successful sale of 2e Group to PE-backed medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company’s growth to over $1.1 billion in enterprise value.
Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his deep expertise in entrepreneurial leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value.
In addition to founding EONOVA, Ross is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services. He is frequently engaged by PE and VC investors to evaluate acquisition targets, conduct commercial due diligence, and develop post-close growth strategies.
Ross is a Certified Exit Planning Advisor (CEPA) with the Exit Planning Institute, an Agency Council Member of Forbes, and Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents’ Organization (YPO). He is also the founder of TEDx ThinkWell and TechStars Startup Weekend HealthBio, and Silver Entrepreneur of the Year for Medical Marketing & Media.
He holds a Bachelor of Science in Advertising & Journalism from Texas A&M University.
INSIGHTS & PERSPECTIVES FROM INDUSTRY EXPERTS
Actionable insights, strategic thinking, and expert advice to help you plan, prepare, and succeed in your exit journey.
Featured
Thought Leadership
The Risk of Letting the Market Define Your Exit
June 17, 2026
For many entrepreneurs, an exit represents the culmination of years of disciplined execution and risk-taking. Yet despite the central role it plays in long-term wealth creation, it is often one of the…
Featured
In the News
GIVE MORE & GET WEALTHIER DOING IT
June 1, 2026
Featured
Podcasts & Videos
The M&A Truths No One Tells Founders
May 29, 2026
In a recent episode of the InOrganic Podcast, hosts Ayelet Shipley and Christian Hassold sit down with Brenda Jacobsen, STS Managing Director, to explore what it really takes to prepare for a successf…
Thought Leadership
Why Discipline Matters in an Exit
May 15, 2026
For many entrepreneurs, selling a business represents the culmination of years of dedication, risk-taking, and persistence. It is not only an emotional milestone but also a significant financial event…
Podcasts & Videos
The Extraordinary Exit: Paths & Journeys That Make a Difference
May 4, 2026
In a recent episode of Conversation with Legends, host Stephen Christie sits down with Andy Harris, STS President of North American Strategies and Managing Director, to explore what it really takes to…
In the News